Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Holmberg

Showing results (151-160 of 287) with videos related to

Pageof 29
Sort By:
NPJ Breast Cancer|June 2, 2021
Risk of primary lung cancer after adjuvant radiotherapy in breast cancer-a large population-based studyAnna-Karin Wennstig, Charlotta Wadsten, Hans Garmo, et al.
Journal of the National Cancer Institute|April 5, 2007
Prostate-specific antigen levels as a predictor of lethal prostate cancerKatja Fall, Hans Garmo, Ove Andrén, et al.
Breast (Edinburgh, Scotland)|December 6, 2023
Association of clinicopathologic variables and patient preference with the choice of surgical treatment for early-stage breast cancer: A registry-based studyEmma Söderberg, Fredrik Wärnberg, Anna-Karin Wennstig, et al.
Nutrition and Cancer|December 12, 2013
Dietary patterns and prostate cancer risk: report from the population based ULSAM cohort study of Swedish menErika Ax, Hans Garmo, Birgitta Grundmark, et al.
BJU International|September 24, 2017
Drugs for metabolic conditions and prostate cancer death in men on GnRH agonistsCecilia Bosco, Chloe Wong, Hans Garmo, et al.
Cancer Causes & Control : CCC|May 8, 2013
Iron metabolism and risk of cancer in the Swedish AMORIS studyAnjali Gaur, Helen Collins, Wahyu Wulaningsih, et al.
European Urology|December 1, 2018
Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate CancerKerri Beckmann, Hans Garmo, Jan Adolfsson, et al.
Carcinogenesis|July 2, 2015
Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patientsWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
Breast Cancer Research and Treatment|May 7, 2018
Risk of ischemic heart disease after radiotherapy for ductal carcinoma in situC Wadsten, A-K Wennstig, H Garmo, et al.
International Journal of Cancer|May 11, 2018
Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitusChristel Häggström, Mieke Van Hemelrijck, Hans Garmo, et al.
Pageof 29

Showing results (151-160 of 287) with videos related to

Sort By:
Pageof 29
NPJ Breast Cancer|June 2, 2021
Risk of primary lung cancer after adjuvant radiotherapy in breast cancer-a large population-based studyAnna-Karin Wennstig, Charlotta Wadsten, Hans Garmo, et al.
Journal of the National Cancer Institute|April 5, 2007
Prostate-specific antigen levels as a predictor of lethal prostate cancerKatja Fall, Hans Garmo, Ove Andrén, et al.
Breast (Edinburgh, Scotland)|December 6, 2023
Association of clinicopathologic variables and patient preference with the choice of surgical treatment for early-stage breast cancer: A registry-based studyEmma Söderberg, Fredrik Wärnberg, Anna-Karin Wennstig, et al.
Nutrition and Cancer|December 12, 2013
Dietary patterns and prostate cancer risk: report from the population based ULSAM cohort study of Swedish menErika Ax, Hans Garmo, Birgitta Grundmark, et al.
BJU International|September 24, 2017
Drugs for metabolic conditions and prostate cancer death in men on GnRH agonistsCecilia Bosco, Chloe Wong, Hans Garmo, et al.
Cancer Causes & Control : CCC|May 8, 2013
Iron metabolism and risk of cancer in the Swedish AMORIS studyAnjali Gaur, Helen Collins, Wahyu Wulaningsih, et al.
European Urology|December 1, 2018
Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate CancerKerri Beckmann, Hans Garmo, Jan Adolfsson, et al.
Carcinogenesis|July 2, 2015
Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patientsWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
Breast Cancer Research and Treatment|May 7, 2018
Risk of ischemic heart disease after radiotherapy for ductal carcinoma in situC Wadsten, A-K Wennstig, H Garmo, et al.
International Journal of Cancer|May 11, 2018
Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitusChristel Häggström, Mieke Van Hemelrijck, Hans Garmo, et al.
Pageof 29